The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.47
Bid: 3.20
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.44 (13.75%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Approval for Sale of Harpin aß Granted in Poland

1 Aug 2023 07:00

RNS Number : 8199H
Plant Health Care PLC
01 August 2023
 

RNS

01 August 2023

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Approval for Sale of Harpin αβ Granted in Poland

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that Harpin αβ, the Company's core, high-value fertilizer product with biostimulant properties, has successfully achieved Mutual Recognition in Poland. This is a major milestone for the Company, and permits immediate sales of Harpin αβ in Poland. Poland is the sixth largest agricultural producer in the EU, and the second largest potato producer behind Germany, growing around 322,000 hectares.

 

Following the initial regulatory approval in France in October 2022, Plant Health Care has pursued Mutual Recognition to expand the use of Harpin αβ across Europe and Poland is the first EU country to grant this status for Harpin αβ.. Europe is the world's largest market for sustainable agriculture with annual sales of over $2 billion.

 

Harpin αβ is a recombinant protein that acts as a powerful biostimulant, improving the yield and quality of crops. Plant Health Care is launching Harpin αβ for use in European potato production, followed by fruit and vegetable crops. Potato field trials are currently underway in Germany, France, Belgium and the Netherlands to demonstrate the value of Harpin αβ. The Company sells Harpin αβ through specialist distributors around the world. Visits to the field trials with interested distributors to observe the results of Harpin αβ on treated potato plants are planned for mid-August.

 

Angel Marin, Director EMEAA for Plant Health Care, said: ‟Expanding the use of our core product, Harpin αβ, in Europe's biggest agricultural markets has been a long-term goal of mine. The granting of Mutual Recognition by Poland brings us one-step closer and the Company expects to select our distribution partner for France, Poland and other EU countries by the end of the year. Harpin αβ is an environmentally friendly, and proven protein technology which improves plant growth and development resulting in higher quality, yields and long-term storage stability, which are vital as the world becomes more concerned about food security."

 

For further information, please contact: 

 Plant Health Care plc  Jeff Tweedy, CEO

 

+1 919 926 1600

 Cenkos Securities plc - Nomad & Broker  Neil McDonald / Pete Lynch

 

+44 (0) 131 220 9771

 SEC Newgate (Financial Communications)  Robin Tozer / Harry Handyside / George Esmond

+44 (0)7540 106 366 phc@secnewgate.co.uk

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. 

 

Find out more at www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFLLXXDLZBBK
Date   Source Headline
9th May 20131:20 pmRNSResult of AGM
7th May 201310:00 amRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSPHC and Arysta LifeScience sign license agreement
19th Apr 20133:30 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:33 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
16th Apr 20138:23 amRNSRe. Investment
15th Apr 20131:30 pmRNSResult of General Meeting
8th Apr 20135:45 pmRNSPublication of Annual Report and Notice of AGM
2nd Apr 20137:00 amRNSConfirmation of Board Changes
27th Mar 20137:00 amRNSPosting of Circular to Shareholders
26th Mar 20134:19 pmRNSBoard Changes
26th Mar 20134:19 pmRNSPlacing and Subscription
26th Mar 20134:18 pmRNSFinal Results
20th Mar 201311:35 amRNSPHC reaches milestone agreement with Germains
11th Mar 20137:00 amRNSMarket Update
19th Feb 20135:45 pmRNSBlock Listing Six-Monthly Return
24th Jan 20139:30 amRNSHarpin field trials results
18th Jan 20135:00 pmRNSNotification of Major Interest in Shares
10th Jan 201312:45 pmRNSTrading Update
31st Dec 201212:25 pmRNSTotal Voting Rights
30th Nov 201211:45 amRNSTotal Voting Rights
2nd Nov 201212:15 pmRNSNotification of Major Interest in Shares
23rd Oct 20127:00 amRNSNotification of Major Interest in Shares
22nd Oct 20122:00 pmRNSNotification of Major Interest in Shares
19th Oct 20123:10 pmRNSNotification of Major Interest in Shares
9th Oct 20127:00 amRNSStrong uptake of new product
8th Oct 20127:00 amRNSNotification of Major Interest In Shares
13th Sep 20127:00 amRNSSignificant progress in SA 2013 maize crop season
31st Aug 20125:00 pmRNSTotal Voting Rights
30th Aug 20122:47 pmRNSHolding(s) in Company
28th Aug 20129:40 amRNSPosting of Interim Report
24th Aug 20122:30 pmRNSDirector/PDMR Shareholding
20th Aug 201212:45 pmRNSAIM Blocklisting Interim Return
20th Aug 20127:00 amRNSHalf Yearly Report
14th Aug 20127:00 amRNSHolding(s) in Company
1st Aug 201212:15 pmRNSDirectorate Change
30th Jul 201212:15 pmRNSNotification of Major Interest in Shares
27th Jul 20127:00 amRNSPotato yield increased through PHC's Harpin
18th Jul 20127:00 amRNSHolding(s) in Company
17th Jul 20127:00 amRNSHolding(s) in Company
28th Jun 20127:00 amRNSHolding(s) in Company
17th May 20127:00 amRNSResearch cooperation with University of Arkansas
3rd May 201212:00 pmRNSHolding(s) in Company
1st May 20125:00 pmRNSTotal Voting Rights
27th Apr 201211:49 amRNSResearch Agreement with Arysta LifeScience

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.